GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.609
-0.020 (-3.24%)
At close: Dec 5, 2025, 4:00 PM EST
0.603
-0.006 (-1.05%)
After-hours: Dec 5, 2025, 7:03 PM EST
GT Biopharma Employees
GT Biopharma had 1 employees as of December 31, 2024. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$9,327,000
Market Cap
6.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GTBP News
- 16 days ago - GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials - Accesswire
- 21 days ago - GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - GT Biopharma Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2 - GlobeNewsWire
- 6 months ago - GT Biopharma Appoints New Member to its Board of Directors - GlobeNewsWire
- 7 months ago - GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals - GlobeNewsWire
- 10 months ago - GT Biopharma Announces Exercise of Warrants - GlobeNewsWire
- 1 year ago - GT Biopharma Reports Third Quarter 2024 Financial Results - GlobeNewsWire